期刊文献+

心血管疾病治疗药物新进展 被引量:2

Cardiovascular Disease Treatment is Reviewed
下载PDF
导出
摘要 目前心血管疾病患者数量大幅上升,为了达到高质量的治疗效果,医学界正致力于各类新药和新治疗方法的研究。本文搜集了国外近几年相关文献,主要从新型肾素抑制剂、血管紧张素受体-脑啡肽酶双重阻滞剂等方面予以阐述,为心血管病的药物治疗提供参考。 At present,the number of patients with cardiovascular disease increased substantially,in order to achieve high-quality therapeutic effect,the medical profession is working on all kinds of new drugs and treatments. The paper collected relevant literature recent years,mainly from the novel renin inhibitor,a combination of the angiotensin receptor blocker valsartan and the neprilysin inhibitor sacubitril,etc. To provide a reference for the treatment of cardiovascular disease.
出处 《哈尔滨医药》 2016年第1期83-85,共3页 Harbin Medical Journal
关键词 高血压 药物治疗 进展 Cardiovascular disease Drug treatment Progress
  • 相关文献

参考文献6

  • 1Parving HH, Brenner BM, McMurray JJ. Cardiorenal and points in a trim of aliskiren for type 2 diabetes [ J ]. N Engl J Med,2012, 367(23) :2204 -2213. 被引量:1
  • 2Filippatos G , Farmakis D , Parissis J , et al. Drug therapy for patients with systolic heart failure after the PARADIGM - HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice [ J ]. BMC Med,2015,13 (1) : 272 -278. 被引量:1
  • 3Gheorghiade M , Bachm M , Greene SJ ,et al. Effect of aliskiren on postdischarge mortality and heart failure re- admissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial[ J ]. JAMA, 2013 , 309 (11) : 1125 -1135. 被引量:1
  • 4Waeber B , Feihl F. Blood- pressure reduction withI.EZ696[J]. Lancet, 2010 ,375 (9722):1228-1129. 被引量:1
  • 5Ruilope LM , Dukat A , Bochm M ,et al. Blood -pressure reduction with I_EZOS, a novel dual - acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double - blind, placebo - controlled, active comparator study [ J ]. Lancet,2010, 375 (9722):1255-1166. 被引量:1
  • 6Bakris GL , Sica D , White WB , et al. Antihypertens- iveEfficacy of Hydrochlorothiazidevs ChlorthalidoneCom- binedwith AzilsartanMedoxomil [ J ]. Am J Med, 2012 ,125 (12): 1229 -1234. 被引量:1

同被引文献45

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部